Works by Montastruc, J. L.

Results: 50

Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.

Published in:

European Journal of Clinical Pharmacology, 2009, v. 65, n. 8, p. 839, doi. 10.1007/s00228-009-0647-2

By:

Lacroix, I.;
Hurault, C.;
Sarramon, M. F.;
Guitard, C.;
Berrebi, A.;
Grau, M.;
Albouy-Cossard, C.;
Bourrel, R.;
Elefant, E.;
Montastruc, J. L.;
Damase-Michel, C.

Publication type:

Article

Was the thrombotic risk of rofecoxib predictible from the French Pharmacovigilance Database before 30 September 2004?

Published in:

European Journal of Clinical Pharmacology, 2008, v. 64, n. 8, p. 829, doi. 10.1007/s00228-008-0497-3

By:

Sommet, A.;
Grolleau, S.;
Bagheri, H.;
Lapeyre-Mestre, M.;
Montastruc, J. L.

Publication type:

Article

Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database.

Published in:

European Journal of Clinical Pharmacology, 2007, v. 63, n. 8, p. 801, doi. 10.1007/s00228-007-0332-2

By:

Lugardon, S.;
Roussel, H.;
Sciortino, V.;
Montastruc, J. L.;
Lapeyre-Mestre, M.

Publication type:

Article

COX-2 inhibitors and arterial hypertension: an analysis of spontaneous case reports in the Pharmacovigilance database.

Published in:

European Journal of Clinical Pharmacology, 2005, v. 61, n. 8, p. 611, doi. 10.1007/s00228-005-0964-z

By:

Durrieu, G.;
Olivier, P.;
Montastruc, J. L.

Publication type:

Article

“Medicamentation” of society, non-diseases and non-medications: a point of view from social pharmacology.

Published in:

European Journal of Clinical Pharmacology, 2005, v. 61, n. 4, p. 309, doi. 10.1007/s00228-005-0925-6

By:

Mbongue, T. B.;
Sommet, A.;
Pathak, A.;
Montastruc, J. L.

Publication type:

Article

Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 285, doi. 10.1007/s00228-004-0760-1

By:

Dugué, A.;
Bagheri, H.;
Lapeyre-Mestre, M.;
Tournamille, J. F.;
Sailler, L.;
Dedieu, G.;
Salvayre, R.;
Thouvenot, J. P.;
Massip, P.;
Montastruc, J. L.

Publication type:

Article

Forged medical prescriptions in a community pharmacy network in Midi-Pyrénées area: assessment of a falsification ratio.

Published in:

European Journal of Clinical Pharmacology, 2002, v. 57, n. 12, p. 911, doi. 10.1007/s00228-001-0412-7

By:

Llau, M. E.;
Lapeyre-Mestre, M.;
Plas, L.;
Damase-Michel, C.;
Montastruc, J. L.

Publication type:

Article

Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.

Published in:

European Journal of Neurology, 2006, v. 13, n. 3, p. 209, doi. 10.1111/j.1468-1331.2006.01262.x

By:

Ferreira, J. J.;
Desboeuf, K.;
Galitzky, M.;
Thalamas, C.;
Brefel-Courbon, C.;
Fabre, N.;
Senard, J.-M.;
Montastruc, J.-L.;
Sampaio, C.;
Rascol, O.

Publication type:

Article

Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy.

Published in:

2016

By:

Bondon-Guitton, E.;
Combret, S.;
Pérault-Pochat, M.;
Stève-Dumont, M.;
Bagheri, H.;
Huguet, F.;
Despas, F.;
Pathak, A.;
Montastruc, J.;
Pérault-Pochat, M C;
Stève-Dumont, M;
Montastruc, J L

Publication type:

journal article

Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.

Published in:

2001

By:

Montastruc, Jean-Louis;
Desboeuf, Karine;
Lapeyre-Mestre, Maryse;
Senard, Jean-Michel;
Rascol, Olivier;
Brefel-Courbon, Christine;
Montastruc, J L;
Desboeuf, K;
Lapeyre-Mestre, M;
Senard, J M;
Rascol, O;
Brefel-Courbon, C

Publication type:

journal article

Treatment of Parkinson's disease should begin with a dopamine agonist.

Published in:

1999

By:

Montastruc, Jean Louis;
Rascol, Olivier;
Senard, Jean-Michel;
Montastruc, J L;
Rascol, O;
Senard, J M

Publication type:

journal article

Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.

Published in:

Movement Disorders, 1995, v. 10, n. 2, p. 163, doi. 10.1002/mds.870100206

By:

Rascol, O.;
Sabatini, U.;
Fabre, N.;
Senard, J. M.;
Simonetta-Moreau, M.;
Montastruc, J. L.;
Clanet, M.;
Rascol, A.

Publication type:

Article

Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 12, p. 2650, doi. 10.1093/jac/dkq351

By:

Gallini, A.;
Degris, E.;
Desplas, M.;
Bourrel, R.;
Archambaud, M.;
Montastruc, J.-L.;
Lapeyre-Mestre, M.;
Sommet, A.

Publication type:

Article

Safety of oseltamivir during pregnancy: a comparative study using the EFEMERIS database.

Published in:

BJOG: An International Journal of Obstetrics & Gynaecology, 2014, v. 121, n. 7, p. 895, doi. 10.1111/1471-0528.12617

By:

Beau, A‐B;
Hurault‐Delarue, C;
Vial, T;
Montastruc, J‐L;
Damase‐Michel, C;
Lacroix, I

Publication type:

Article

α-Adrenoceptor Antagonists: A New Approach to Parkinson's Disease?

Published in:

CNS Drugs, 1998, v. 10, n. 3, p. 189, doi. 10.2165/00023210-199810030-00004

By:

Brefel-Courbon, C.;
Thalamas, C.;
Saint Paul, H.P.;
Senard, J-M.;
Montastruc, J-L.;
Rascol, O.

Publication type:

Article

Does papaverine interact with levodopa in Parkinson's disease?

Published in:

1987

By:

Montastruc, J. L.;
Rascol, O.;
Belin, J.;
Ane, M.;
Rascol, A.

Publication type:

clinical trial

Buprenorphine in pregnant opioid-dependent women: first results of a prospective study.

Published in:

Addiction, 2004, v. 99, n. 2, p. 209, doi. 10.1046/j.1360-0443.2003.00600.x

By:

Lacroix, I.;
Berrebi, A.;
Chaumerliac, C.;
Lapeyre‐Mestre, M.;
Montastruc, J. L.;
Damase‐Michel, C.

Publication type:

Article

Glucose-induced sympathetic activity and energy expenditure during acute α2-adrenergic antagonism in obese subjects.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2000, v. 24, n. 6, p. 695, doi. 10.1038/sj.ijo.0801221

By:

Thalamas, C;
Galitzky, J;
Sénard, J M;
Lafontan, M;
Montastruc, J L;
Berlan, M;
Barbe, P

Publication type:

Article

Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study.

Published in:

2000

By:

Sabatini, U;
Boulanouar, K;
Fabre, N;
Martin, F;
Carel, C;
Colonnese, C;
Bozzao, L;
Berry, I;
Montastruc, J L;
Chollet, F;
Rascol, O

Publication type:

journal article

The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients.

Published in:

Brain: A Journal of Neurology, 1997, v. 120, n. 1, p. 103, doi. 10.1093/brain/120.1.103

By:

Rascol, O;
Sabatini, U;
Fabre, N;
Brefel, C;
Loubinoux, I;
Celsis, P;
Senard, J M;
Montastruc, J L;
Chollet, F

Publication type:

Article

Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanisms.

Published in:

British Journal of Pharmacology, 1999, v. 127, n. 7, p. 1657, doi. 10.1038/sj.bjp.0702678

By:

Lazartigues, E;
Brefel-Courbon, C;
Tran, M A;
Montastruc, J L;
Rascol, O

Publication type:

Article

Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: a study from the French PharmacoVigilance Database.

Published in:

Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 10, p. 735, doi. 10.1002/pds.1284

By:

Michenot, F.;
Sommet, A.;
Bagheri, H.;
Lapeyre-Mestre, M.;
Montastruc, J. L.

Publication type:

Article

Psychoactive drug consumption: performance-enhancing behaviour and pharmacodependence in workers.

Published in:

Pharmacoepidemiology & Drug Safety, 2005, v. 14, n. 2, p. 81, doi. 10.1002/pds.1006

By:

Ngoundo-Mbongue, T. B.;
Niezborala, M.;
Sulem, P.;
Briant-Vincens, D.;
Bancarel, Y.;
Jansou, P.;
Chastan, E.;
Montastruc, J. L.;
Lapeyre-Mestre, M.

Publication type:

Article

Drug counselling in pregnancy: an opinion survey of French community pharmacists.

Published in:

Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 10, p. 711, doi. 10.1002/pds.954

By:

Damase-Michel, Christine;
Vié, Céline;
Lacroix, Isabelle;
Lapeyre-Mestre, Maryse;
Montastruc, J. L.

Publication type:

Article

Treatment of acute renal colic in a French emergency department: a comparison of simulated cases and real cases in acute pain assessment and management.

Published in:

European Journal of Clinical Pharmacology, 2001, v. 57, n. 9, p. 685, doi. 10.1007/s002280100366

By:

Jean, R.;
Ducasse, J. L.;
Montastruc, J. L.;
Lapeyre-Mestre, M.

Publication type:

Article

Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course.

Published in:

British Journal of Clinical Pharmacology, 2007, v. 64, n. 2, p. 233, doi. 10.1111/j.1365-2125.2007.02882.x

By:

Durrieu, G.;
Hurault, C.;
Bongard, V.;
Damase-Michel, C.;
Montastruc, J. L.

Publication type:

Article

Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.

Published in:

British Journal of Clinical Pharmacology, 2002, v. 54, n. 4, p. 433, doi. 10.1046/j.1365-2125.2002.01674.x

By:

Bongard, V.;
Ménard-Taché, S.;
Bagheri, H.;
Kabiri, K.;
Lapeyre-Mestre, M.;
Montastruc, J. L.

Publication type:

Article

Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database.

Published in:

2012

By:

Moulis, G;
Béné, J;
Sommet, A;
Sailler, L;
Lapeyre-Mestre, M;
Montastruc, J-L

Publication type:

Case Study

Insulin downregulates M2-muscarinic receptors in adult rat atrial cardiomyocytes: a link between obesity and cardiovascular complications.

Published in:

International Journal of Obesity, 2005, v. 29, n. 2, p. 176, doi. 10.1038/sj.ijo.0802751

By:

Pathak, A.;
Smih, F.;
Galinier, M.;
Verwaerde, P.;
Rouet, P.;
Philip-Couderc, P.;
Montastruc, J. L.;
Senard, J. M.

Publication type:

Article

Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.

Published in:

2002

By:

Olivier, P.;
Boulbés, O.;
Tubery, M.;
Lauque, D.;
Montastruc, J-L.;
Lapeyre-Mestre, M.;
Olivier, Pascale;
Boulbés, Olivier;
Tubery, Marie;
Lauque, Dominique;
Montastruc, Jean-Louis;
Lapeyre-Mestre, Maryse

Publication type:

journal article

Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients.

Published in:

2003

By:

Cestac, P.;
Bagheri, H.;
Lapeyre-Mestre, M.;
Sié, P.;
Fouladi, A.;
Maupas, E.;
Léger, P.;
Fontan, B.;
Massip, P.;
Montastruc, J-L.;
Cestac, Philippe;
Bagheri, Haleh;
Lapeyre-Mestre, Maryse;
Sié, Pierre;
Fouladi, Atoussa;
Maupas, Eric;
Léger, Philippe;
Fontan, Bernard;
Massip, Patrice;
Montastruc, Jean-Louis

Publication type:

journal article

Perception of risk of adverse drug reactions: a 3-year follow-up of a cohort of medical students.

Published in:

Fundamental & Clinical Pharmacology, 2010, v. 24, n. 4, p. 423, doi. 10.1111/j.1472-8206.2009.00783.x

By:

Durrieu, Geneviève;
Hurault, C.;
Damase-Michel, C.;
Montastruc, J. L.

Publication type:

Article

Valvular heart disease in a patient taking benfluorex.

Published in:

Fundamental & Clinical Pharmacology, 2006, v. 20, n. 6, p. 577, doi. 10.1111/j.1472-8206.2006.00441.x

By:

Noize, P.;
Sauer, M.;
Bruneval, P.;
Moreau, M.;
Pathak, A.;
Bagheri, H.;
Montastruc, J. L.

Publication type:

Article

ORIGINAL ARTICLE Nonsteroidal anti-inflammatory drug-induced liver injury: a case–control study in primary care.

Published in:

Fundamental & Clinical Pharmacology, 2004, v. 18, n. 2, p. 201, doi. 10.1111/j.1472-8206.2004.00224.x

By:

Lacroix, I.;
Lapeyre-Mestre, M.;
Bagheri, H.;
Pathak, A.;
Montastruc, J. L.

Publication type:

Article

PLASMA CATECHOLAMINES AND ADRENOCEPTORS AFTER CHRONIC SINOAORTIC DENERVATION IN DOGS.

Published in:

Fundamental & Clinical Pharmacology, 1989, v. 3, n. 3, p. 307, doi. 10.1111/j.1472-8206.1989.tb00459.x

By:

VALET, P.;
DAMASE-MICHEL, C.;
MONTASTRUC, J.-L.;
MONTASTRUC, P.

Publication type:

Article

A Comparative Survey of Antidepressant Drug Prescribing Habits of General Practitioners and Psychiatrists.

Published in:

Clinical Drug Investigation, 1998, v. 16, n. 1, p. 53, doi. 10.2165/00044011-199816010-00007

By:

Lapeyre-Mestre, M.;
desboeuf, K.;
Aptel, I.;
Chale, J-J.;
Montastruc, J-L.

Publication type:

Article

N-methyl- D-aspartate (NMDA) antagonist and Parkinson's disease: A pilot study with dextromethorphan.

Published in:

Movement Disorders, 1994, v. 9, n. 2, p. 242, doi. 10.1002/mds.870090226

By:

Montastruc, J. L.;
Fabre, N.;
Rascol, O.;
Senard, J. M.;
Blin, O.

Publication type:

Article

Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease.

Published in:

Movement Disorders, 1987, v. 2, n. 4, p. 279, doi. 10.1002/mds.870020405

By:

Montastruc, J. L.;
Celsis, P.;
Agniel, A.;
Demonet, J. F.;
Doyon, B.;
Puel, M.;
Marc-Vergnes, J. P.;
Rascol, A.

Publication type:

Article

Neurohypophysial peptides and central cardiovascular control.

Published in:

European Heart Journal, 1983, v. 4, n. suppl_G, p. 47, doi. 10.1093/eurheartj/4.suppl_g.47

By:

Montastruc, J. L.;
Dang Tran, L.;
Montastruc, P.

Publication type:

Article

Peripheral arterial occlusive disease during ponatinib therapy after failure of imatinib: a case report.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 3, p. 360, doi. 10.1111/jcpt.12383

By:

Tournaire, G.;
Despas, F.;
Huguet, F.;
Montastruc, J. L.;
Bondon‐Guitton, E.

Publication type:

Article

Ischaemic stroke after exposure to aflibercept: interaction with vitamin K antagonist and/or direct pharmacodynamic effect?

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 4, p. 477, doi. 10.1111/jcpt.12278

By:

Thorel, J.;
Civade, E.;
Quintyn, J. C.;
Cestac, P.;
Montastruc, J.‐L.;
Bagheri, H.

Publication type:

Article

Analysis of patients' narratives posted on social media websites on benfluorex's ( Mediator®) withdrawal in France.

Published in:

2014

By:

Abou Taam, M.;
Rossard, C.;
Cantaloube, L.;
Bouscaren, N.;
Roche, G.;
Pochard, L.;
Montastruc, F.;
Herxheimer, A.;
Montastruc, J. L.;
Bagheri, H.

Publication type:

Journal Article

Analysis of patients' narratives posted on social media websites on benfluorex's ( Mediator®) withdrawal in France.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 1, p. 53, doi. 10.1111/jcpt.12103

By:

Abou Taam, M.;
Rossard, C.;
Cantaloube, L.;
Bouscaren, N.;
Roche, G.;
Pochard, L.;
Montastruc, F.;
Herxheimer, A.;
Montastruc, J. L.;
Bagheri, H.

Publication type:

Article

Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension.

Published in:

European Journal of Clinical Investigation, 1990, v. 20, n. 6, p. 613, doi. 10.1111/j.1365-2362.1990.tb01909.x

By:

SENARD, J. M.;
VALET, P.;
DURRIEU, G.;
BERLAN, M.;
TRAN, M. A.;
MONTASTRUC, J. L.;
RASCOL, A.;
MONTASTRUC, P.

Publication type:

Article

Platelet α.

Published in:

European Journal of Clinical Investigation, 1988, v. 18, n. 5, p. 481, doi. 10.1111/j.1365-2362.1988.tb01043.x

By:

VALET, P.;
DAMASE-MICHEL, C.;
CHAMONTIN, B.;
DURAND, D.;
CHOLLET, F.;
MONTASTRUC, J. L.

Publication type:

Article

Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 3, p. 239, doi. 10.1007/s00702-002-0799-z

By:

Fénelon, G.;
Gliménez-Roldán, S.;
Montastruc, J. L.;
Bermejo, F.;
Durif, F.;
Bourdeix, I.;
Péré, J.-J.;
Galiano, L.;
Schadrack, J.

Publication type:

Article

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by l-dopa.

Published in:

Journal of Neural Transmission, 2002, v. 109, n. 4, p. 489, doi. 10.1007/s007020200040

By:

Brunt, E. R.;
Brooks, D. J.;
Korczyn, A. D.;
Montastruc, J.-L.;
Stocchi, F.

Publication type:

Article

A comparative study of adverse drug reactions reported through hospital and private medicine.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 166, doi. 10.1111/j.1365-2125.1996.tb00177.x

By:

LEMOZIT, J. P.;
RHODIERE, G. PETIT;
LAPEYRE-MESTRE, M.;
BAGHERI, H.;
MONTASTRUC, J. L.

Publication type:

Article

Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Published in:

2020

By:

Concordet, D.;
Gandia, P.;
Montastruc, J. L.;
Bousquet-Mélou, A.;
Lees, P.;
Ferran, A. A.;
Toutain, P. L.

Publication type:

Letter

Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2014, v. 28, n. 9, p. 1235, doi. 10.1111/jdv.12318

By:

Le Moigne, M.;
Sommet, A.;
Lapeyre ‐ Mestre, M.;
Bourrel, R.;
Molinier, L.;
Paul, C.;
Montastruc, J ‐ .L.

Publication type:

Article